The association between the eGFR slope and cardiorenal prognosis in patients with renoprotective treatments: A systematic review and meta-analysis.
Shuzhen BaiChu LinXiaoling CaiHan WuRuoyang JiaoSuiyuan HuFang LvWenjia YangLinong JiPublished in: Journal of evidence-based medicine (2024)
The eGFR preservation reflected by the positive comparator-adjusted total eGFR slope was associated with a reduced risk of composite renal outcome in patients receiving renoprotective agents. Greater acute decline in eGFR during the initiation of the treatment might confer a trend of fewer renal events in patients receiving SGLT2i, MRA, or RAASi.